Brief: Enveric Biosciences Gets New US Patent For Tryptamine-Derived Prodrugs
28/08/2023 14:18
Aug 28 (Reuters) - Enveric Biosciences Inc ENVB.O :
* ENVERIC BIOSCIENCES STRENGTHENS INTELLECTUAL PROPERTY
PORTFOLIO
WITH NEW U.S. PATENT FOR TRYPTAMINE-DERIVED PRODRUGS
Source text for Eikon: ID:nBw5005K5a
Further company coverage: ENVB.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Enveric Biosciences
See all newsBrief: Enveric Biosciences Announces Positive Results From IND-Enabling ADMET Studies
Enveric Biosciences Q2 net loss widens
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
Brief: Enveric Biosciences Initiates Investigational New Drug (IND)-Enabling Genotoxicity Studies Of Lead Neuroplastogen Candidate EB-003
Brief: Enveric Biosciences Reports Positive Preclinical Results From Phototoxicity Analysis For Lead Neuroplastogen Candidate Eb-003